Eli Lilly and Company — Patent Applications
Published USPTO patent applications filed under applicant “Eli Lilly and Company / ELI LILLY AND COMPANY” — pending requests, not granted patents. Where a filing continues an already-granted parent, the parent’s number is shown.
Newest filing on this page: 2026-01-16. Last loaded from the USPTO Open Data Portal on 2026-06-11. This list is not refreshed on a schedule and was last loaded 135 days ago, so newer applications may be missing. USPTO publishes most applications about 18 months after they are filed.
Applications on file
Every row is a patent application — a pending request, not a granted patent. “Granted Parent” shows the parent patent number when a filing continues an already-granted family. Newest filing date first. Source: USPTO Open Data Portal (public).
| Title | Filed | Application # | Status | Granted Parent |
|---|---|---|---|---|
| MEDICATION DELIVERY DEVICE WITH SENSING SYSTEM | 2026-01-16 | 19450968 | Docketed New Case - Ready for Examination | — |
| METHODS AND APPARATUS FOR DETERMINING DEVICE DOSAGE | 2025-11-26 | 19401661 | Docketed New Case - Ready for Examination | parent 12505906 |
| PLUNGER DRIVE SYSTEM FOR A MEDICATION DELIVERY DEVICE | 2025-11-25 | PCTUS2025056968 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| ATXN2 RNA INTERFERENCE AGENTS | 2025-11-21 | PCTUS2025056497 | PCT - International Search Report Mailed to IB | — |
| AMPK-BETA-1-ACTIVATING COMPOUNDS AND METHODS OF USING THE SAME | 2025-11-19 | PCTUS2025056071 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| METHODS OF USING AND COMPOSITIONS INCLUDING AN INCRETIN ANALOG | 2025-11-18 | 19393199 | Docketed New Case - Ready for Examination | parent 12496329 |
| SUBSTITUTED HETEROARYL-HETEROARYL GLUCAGON RECEPTOR AGONISTS AND THEIR USE AS THERAPIES | 2025-11-18 | PCTUS2025055851 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| METHODS OF USING AND COMPOSITIONS INCLUDING AN INCRETIN ANALOG | 2025-11-18 | 19393216 | Docketed New Case - Ready for Examination | parent 12496329 |
| ALK7 RNA INTERFERENCE AGENTS | 2025-11-17 | PCTUS2025055788 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| PLIN1 RNA INTERFERENCE AGENTS | 2025-11-17 | PCTUS2025055782 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| PLIN1 RNAi INTERFERENCE AGENTS | 2025-11-17 | 19391737 | Docketed New Case - Ready for Examination | — |
| ORAL COMPOSITIONS COMPRISING LP(A) INHIBITOR COMPOUNDS | 2025-11-13 | PCTUS2025055302 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| ORAL COMPOSITIONS COMPRISING LP(A) INHIBITOR COMPOUNDS | 2025-11-13 | 19388561 | Docketed New Case - Ready for Examination | — |
| TRKA RNA INTERFERENCE AGENTS AND USES THEREOF | 2025-11-12 | PCTUS2025055151 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| PRIME DOSE SETTING ASSEMBLY FOR INJECTION DEVICE | 2025-11-06 | PCTUS2025054310 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| MEDICATION DELIVERY DEVICE WITH MEDICATION CARTRIDGE AND NEEDLE ASSEMBLY | 2025-11-06 | PCTUS2025054303 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| GIP/GLP1 AGONIST COMPOSITIONS | 2025-11-04 | 19379195 | Patented Case | parent 12453756 |
| ALK7 RNA INTERFERENCE AGENTS | 2025-10-31 | 63909146 | Application Dispatched from Preexam, Not Yet Docketed | — |
| WASH AFTER DEBLOCK IN SOLID PHASE OLIGONUCLEOTIDE SYNTHESIS | 2025-10-23 | PCTUS2025052206 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| SYSTEMS AND METHODS FOR PERFORMING SOLID PHASE OLIGONUCLEOTIDE SYNTHESIS | 2025-10-23 | PCTUS2025052176 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| DETRITYLATION STEP IN SOLID PHASE OLIGONUCLEOTIDE SYNTHESIS | 2025-10-23 | PCTUS2025052196 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| CAPPING STEP | 2025-10-23 | PCTUS2025052232 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| OXIDATION/ SULFURIZATION STEP AND WASH AFTER OXIDATION/SULFURIZATION | 2025-10-23 | PCTUS2025052225 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| TRKA RNA INTERFERENCE AGENTS AND USES THEREOF | 2025-10-17 | 63901113 | Application Dispatched from Preexam, Not Yet Docketed | — |
| SYSTEMS AND METHODS FOR REMOTE PRESCRIPTION OF MEDICATION-DOSING REGIMENS | 2025-10-10 | 19355120 | Docketed New Case - Ready for Examination | — |
| ANTI-UNC5C ANTIBODIES | 2025-10-09 | 19353681 | Docketed New Case - Ready for Examination | — |
| SOD1 RNA INTERFERENCE AGENTS | 2025-10-09 | PCTUS2025050166 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| NPR-C MEDIATED DELIVERY TO ADIPOSE TISSUE | 2025-10-06 | PCTUS2025049575 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| REAGENTS AND METHODS FOR IMAGING CANCERS EXPRESSING PDGFRALPHA | 2025-10-02 | 19472083 | Application Undergoing Preexam Processing | — |
| SYSTEMS AND METHODS FOR TESTING IDENTIFICATION DEVICES FOR MEDICATION DELIVERY DEVICES | 2025-10-02 | PCTUS2025049215 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| ANTI-CD137 ANTIBODIES | 2025-09-30 | 19346308 | Application Undergoing Preexam Processing | parent 12453771 |
| KRAS INHIBITORS | 2025-09-30 | 19344841 | Patented Case | — |
| PROCESS FOR PREPARING A GIP/GLP1 DUAL AGONIST | 2025-09-26 | 19341996 | Response to Non-Final Office Action Entered and Forwarded to Examiner | — |
| TIRZEPATIDE BINDING MOLECULES, AND USES THEREOF | 2025-09-24 | PCTUS2025047637 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS | 2025-09-24 | 19168359 | Application Undergoing Preexam Processing | — |
| PROCESS FOR PREPARING A GIP/GLP1 DUAL AGONIST | 2025-09-24 | 19338984 | Response to Non-Final Office Action Entered and Forwarded to Examiner | — |
| CONJUGATES COMPRISING BIS-MSPT LINKER | 2025-09-19 | PCTUS2025047055 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| CONJUGATES COMPRISING BIS-MSPT LINKER | 2025-09-19 | 19333454 | Docketed New Case - Ready for Examination | — |
| IMPROVED CHEMICAL METHODS FOR MANUFACTURING A PHOSPHORAMIDITE USED IN RNA SYNTHESIS | 2025-09-18 | PCTUS2025046904 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| PAN-ELR+ CXC CHEMOKINE ANTIBODIES AND IL-23P19 ANTIBODIES FOR THE TREATMENT OF ULCERATIVE COLITIS | 2025-09-12 | PCTUS2025046081 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| STABLE APO ACTIVE FUSION OF A G PROTEIN COUPLED RECEPTOR (GPCR) AND A G PROTEIN ALPHA SUBUNIT HELIX 5 | 2025-09-11 | PCTUS2025045854 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| SYRINGE SYSTEMS AND METHODS FOR DISPENSING DRUG PRODUCTS | 2025-09-10 | PCTUS2025045747 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| KRAS INHIBITORS | 2025-09-10 | PCTUS2025045670 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| COMPOUNDS AND METHODS TARGETING INTERLEUKIN-19 | 2025-09-09 | 19323384 | Docketed New Case - Ready for Examination | parent 12459997 |
| DISSOLVING MICRONEEDLE PATCH FOR TRANSDERMAL DELIVERY OF A PEPTIDE | 2025-09-08 | PCTUS2025045322 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| METHOD OF TREATING ALZHEIMER'S DISEASE USING ANTI-N3PGLU AMYLOID BETA ANTIBODIES | 2025-09-08 | PCTUS2025045352 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
| ANTITUMOR COMBINATIONS CONTAINING ANTI-CEACAM5 ANTIBODY-DRUG CONJUGATES, ANTI-VEGFR-2 ANTIBODIES AND ANTI-PD1/PD-L1 ANTIBODIES | 2025-09-05 | 19162616 | Sent to Classification contractor | — |
| PLIN1 RNA INTERFERENCE AGENTS | 2025-09-03 | 63875101 | Application Dispatched from Preexam, Not Yet Docketed | — |
| NPR-C MEDIATED DELIVERY TO ADIPOSE TISSUE | 2025-08-21 | 63867907 | Application Dispatched from Preexam, Not Yet Docketed | — |
| ENGINEERED REGULATORY SPLICE ELEMENTS FOR GENE THERAPIES | 2025-08-18 | PCTUS2025042340 | RO PROCESSING COMPLETED-PLACED IN STORAGE | — |
How to read this
Every row here is an application — a request the USPTO has not yet decided. In plain English: these filings show where Eli Lilly and Company’s R&D effort is pointed right now, often 18–24 months before any product ships — but an application can be amended, abandoned, or rejected, and most confer no enforceable rights until granted. A “granted parent” tag means the filing continues a patent family that already has a grant — the new claims themselves are still pending. Filings are matched by applicant name, so work filed under subsidiary or research-entity names may not appear. Source: USPTO Open Data Portal (public).
How many Eli Lilly and Company patent applications does this page show?
This page lists 50 U.S. patent applications Oxford Ledge has matched to Eli Lilly and Company, of which 6 continue an already-granted patent family. It is not a count of everything the company has on file. Every row is an application (a pending request to the USPTO), not a granted patent.
What is the difference between a patent application and a granted patent?
A patent application is a pending request filed with the USPTO; a granted patent is one the USPTO has examined and issued. These pages track applications, which signal a company's R&D direction before any patent is granted.
Where does this patent data come from?
The USPTO Open Data Portal (public), matched to the company's applicant registrations.